相关实验视频

Updated: Jul 21, 2025

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

患有中枢神经系统参与的急性淋巴细胞白血病 - 管理方面的挑战

Shruthi Suryaprakash^1,2, Hiroto Inaba^3,4

¹Department of Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Mail Stop 260, Memphis, TN, 38105, USA.

Indian journal of pediatrics

|July 28, 2023

概括

由于更好的诊断和治疗,急性淋巴细胞白血病 (ALL) 的存活率有所提高. 中枢神经系统 (CNS) 白血病仍然是一个挑战,需要优化预防和治疗策略,特别是在LMICs.

科学领域:

血液学血液学血液学
在瘤学瘤学.
儿科瘤学儿科瘤学

背景情况:

在60多年来,急性淋巴细胞白血病 (ALL) 治疗的重大进展改善了患者的生存率.
改善源于加强诊断,风险分层,支持性护理以及免疫治疗和向治疗等新型疗法.

研究的目的:

为了解决有关ALL中中枢神经系统 (CNS) 参与的持久问题.
审查低收入和中等收入国家 (LMICs) 的诊断方法,治疗策略和挑战.

主要方法:

对针对ALL中中枢神经系统活动的治疗方法的当前临床试验数据的审查.
分析与中枢神经系统白血病相关的风险因素和复发模式.
检查特定于LMICs的治疗考虑因素.

主要成果:

虽然整体生存率有所改善,但中枢神经系统白血病仍然是一个关键领域,需要进一步研究和优化管理.
目前的数据突出显示,需要精确的策略来预防中枢神经系统复发和管理现有的中枢神经系统疾病.
对于LMIC患者来说,存在治疗差异和特殊挑战.

结论:

进一步的研究是必要的,以充分理解和管理中枢神经系统参与ALL.
需要优化治疗方案,以减少中枢神经系统复发率并改善治疗结果.
解决LMICs的挑战对于全球公平的ALL护理至关重要.

关键词:

急性淋巴细胞白血病 (Acute Lymphoblastic Leukemia) 是一种急性淋巴细胞白血病.中枢神经系统中枢神经系统诊断诊断诊断诊断诊断管理管理管理管理

更多相关视频

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

相关概念视频

Drug Delivery: Parenteral Route

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...